Snapshot
Support from preclinical to Phase 2
VDS-C is optimized for parenteral molecules in the earliest phases of clinical development. This 50,000 ft2 site offers the resources needed for efficient early-stage clinical manufacturing including chemical analysis, microbiology labs, material preparation and compounding functions.
Key features & resources:
- Aseptic clinical filling
- Lyophilization
- Process development
- Feasibility & stability studies
- Technical & engineering batches
- cGMP clinical batches
- Regulatory support
- Scale-up for late-phase & commercial manufacturing
- Visual inspection
